Synonyms: MZ101
Compound class:
Synthetic organic
Comment: MZ-101 is a preclinical, small molecule, selective inhibitor of glycogen synthase 1 (GYS1; P13807) [1]. It was designed as a strategy for the treatment of glycogen storage disorders such as Pompe disease, via a mechanism that reduces glycogen synthesis and storage in muscle. Inhibition of GYS1 is proposed as an alternative/or adjunct to alpha glucosidase (GAA) enzyme replacement therapy for Pompe disease.
|
|
References |
1. Ullman JC, Mellem KT, Xi Y, Ramanan V, Merritt H, Choy R, Gujral T, Young LEA, Blake K, Tep S et al.. (2024)
Small-molecule inhibition of glycogen synthase 1 for the treatment of Pompe disease and other glycogen storage disorders. Sci Transl Med, 16 (730): eadf1691. [PMID:38232139] |